En esta página
OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares
NASDAQ · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$5,95
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,66mínimo 52 semanas
$6,50máximo 52 semanas
Capitalización Bursátil (MRQ)
$358M
P/E (TTM)
-7.2
BPA (TTM)
$-0.83
Ingresos (TTM)
$32M
tus insignias
Rango 52S
$3–$6
Calificación del Analista
BUY
Precio Objetivo
$12
P/E
-7.2
ROE
-601.8%
Margen de Beneficio Neto
-184.6%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
OBIO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$5.95
Capitalización Bursátil (MRQ)
$358M
P/E (TTM)
-7.2
BPA (TTM)
$-0.83
Ingresos (TTM)
$32M
ROE (TTM)
-601.8%
Rango 52S
$3–$7
OBIO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$33M2022-12-31 → 2025-12-31
BPA$-1.112021-12-31 → 2025-12-31
Flujo de caja libre$-49M2023-12-31 → 2025-12-31
Margen neto-184.6%2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | OBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -7.2promedio 5A ≈-104.2 | ≈-104.2 | · | · | |
| P/S (TTM) | 11.2promedio 5A ≈49.0 | ≈49.0 | 5.5 | Sobrevalorado | |
| P/C (MRQ) | 18.5promedio 5A ≈-0.8 | ≈-0.8 | 4.6 | Sobrevalorado | |
| Precio / FCF (TTM) | -6.1promedio 5A ≈-5.0 | ≈-5.0 | · | · | |
| Precio / Flujo de Caja (TTM) | -6.1promedio 5A ≈-41.6 | ≈-41.6 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 6.3promedio 5A ≈3.7 | ≈3.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | OBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -181.4%promedio 5A ≈-1486.1% | ≈-1486.1% | -58.4% | Débil | |
| Margen EBITDA (TTM) | -180.3%promedio 5A ≈-1478.4% | ≈-1478.4% | -58.4% | Débil | |
| Margen de Beneficio Neto (TTM) | -184.6%promedio 5A ≈-1416.8% | ≈-1416.8% | -57.3% | Débil | |
| ROA (TTM) | -74.5%promedio 5A ≈-36.1% | ≈-36.1% | -32.6% | Débil | |
| ROE (TTM) | -601.8%promedio 5A ≈-83.3% | ≈-83.3% | -106.9% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | OBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 8.3promedio 5A ≈5.9 | ≈5.9 | 4.9 | Liquidez sólida | |
| Ratio Rápido (MRQ) | 8.2promedio 5A ≈5.8 | ≈5.8 | 3.7 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | OBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 1169.2%promedio 5A ≈381.0% | ≈381.0% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 111.6% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | OBIO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.4promedio 5A ≈0.1 | ≈0.1 | 0.6 | Débil | |
| Inventory Turnover (Rotación de Inventario) | 0.8promedio 5A ≈1.0 | ≈1.0 | 1.5 | Débil | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 358.1promedio 5A ≈138.0 | ≈138.0 | 6.6 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$389.3K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
18.1%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 18, 2026 | $-0.38 | $-0.40 | 5.0% |
| 31 de marzo de 2026 | May 18, 2026 | $-0.33 | $-0.44 | 24.9% |
| 31 de diciembre de 2025 | $-0.13 | $-0.39 | 66.3% | |
| 30 de septiembre de 2025 | $-0.40 | $-0.44 | 9.8% | |
| 30 de junio de 2025 | $-0.50 | $-0.51 | 2.7% | |
| 31 de marzo de 2025 | $-0.49 | $-0.49 | 0.12% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $33M | $3M | $3M | $4M | |
| Cost of Revenue | $190.0K | $204.0K | $186.0K | $211.0K | |
| R&D Expense | $58M | $43M | $34M | $22M | |
| SG&A Expense | $27M | $24M | $20M | $14M | |
| Operating Expenses | $85M | $67M | $54M | $36M | |
| Operating Income | $-52M | $-64M | $-52M | $-33M | |
| Interest Income | · | · | · | $345.1K | |
| Other Non-op | · | $-11.0K | · | · | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-53M | $-61M | $-49M | $-34M | |
| EPS (Basic) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| EPS (Diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| Shares (Basic) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| Shares (Diluted) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| EBITDA | $-51M | $-64M | $-51M | $-3M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $22M | $31M | $20M | |
| Short-term Investments | $72M | $45M | $57M | $64M | |
| Receivables | $95.0K | $92.0K | $99.0K | $96.0K | |
| Inventory | $310.0K | $173.0K | $146.0K | $276.0K | |
| Prepaid Expense | $994.0K | $2M | $1M | $533.0K | |
| Current Assets | $108M | $69M | $89M | $85M | |
| PP&E (Net) | $2M | $1M | $1M | $1M | |
| PP&E (Gross) | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $778.0K | |
| Total Assets | $115M | $76M | $95M | $96M | |
| Accounts Payable | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $10M | $6M | $5M | $5M | |
| Current Liabilities | $17M | $16M | $11M | $19M | |
| Capital Leases | $936.0K | $2M | $1M | $2M | |
| Deferred Tax | $393.0K | $561.0K | $508.0K | $637.0K | |
| Other Non-current Liabilities | $308.0K | $40.0K | · | $196.0K | |
| Total Liabilities | $51M | $43M | $27M | $43M | |
| Long-term Debt | $15M | $15M | · | · | |
| Common Stock | $6.0K | $4.0K | $4.0K | $2.0K | |
| Paid-in Capital | $416M | $343M | $317M | $252M | |
| Retained Earnings | $-363M | $-310M | $-249M | $-200M | |
| AOCI | $60.0K | $52.0K | $-10.0K | $-8.0K | |
| Stockholders' Equity | $54M | $33M | $68M | $53M | |
| Liabilities + Equity | $115M | $76M | $95M | $96M | |
| Shares Outstanding | 57,032,963 | 38,194,442 | 35,777,412 | 20,187,850 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $327.0K | $308.0K | $287.0K | $222.0K | |
| Stock-based Comp | $12M | $11M | $8M | $3M | |
| Other Non-cash | $-9M | $-457.0K | $-5M | · | |
| Operating Cash Flow | $-49M | $-51M | $-46M | $-29M | |
| CapEx | $489.0K | $289.0K | $78.0K | $591.0K | |
| Investing Cash Flow | $-27M | $13M | $11M | $-64M | |
| Net Debt Issued | · | · | $-11M | · | |
| Financing Cash Flow | $88M | $29M | $46M | $103M | |
| Net Change in Cash | $12M | $-8M | $11M | $10M | |
| Free Cash Flow | $-49M | $-51M | $-46M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -154.7% | -2437.5% | -1866.2% | · | |
| Net Margin | -157.4% | -2313.3% | -1779.7% | · | |
| EBITDA Margin | -153.8% | -2425.8% | -1855.8% | · | |
| ROA | -55.2% | -71.2% | -51.5% | -2.4% | |
| ROE | -195.7% | -154.2% | -66.5% | -10.0% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 6.4 | 4.3 | 8.0 | 0.2 | |
| Quick Ratio | 6.4 | 4.1 | 7.8 | 0.1 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.8 | 1.3 | 0.9 | · | |
| Receivables Turnover | 358.1 | 27.6 | 28.3 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.94 | $0.86 | $1.90 | $-1.56 | |
| Revenue / Share | $0.70 | $0.07 | $0.08 | · | |
| Cash Flow / Share | $-1.03 | $-1.37 | $-1.39 | $-0.10 | |
| Cash / Share | $0.61 | $0.58 | $0.85 | $0.04 | |
| EPS (TTM) | $-1.11 | $-1.66 | $-1.48 | $-2.24 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 1169.2% | -4.4% | -21.9% | · | |
| Revenue CAGR 3Y | 111.6% | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $33M | $3M | $3M | $4M | |
| Net Income TTM | $-53M | $-61M | $-49M | $-34M | |
| Market Cap | $237M | $153M | $327M | $44M | |
| P/E | -3.7 | -2.4 | -6.2 | -4.5 | |
| P/S | 7.1 | 57.9 | 118.4 | 12.6 | |
| P/B | 4.4 | 4.6 | 4.8 | -6.4 | |
| P / Tangible Book | 4.4 | 4.6 | 4.8 | 0.8 | |
| P / Cash Flow | -4.8 | -3.0 | -7.1 | -28.1 | |
| P / FCF | -4.8 | -3.0 | -7.1 | · | |
| Earnings Yield | -26.8% | -41.5% | -16.2% | -22.4% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0K | $110.0K | $31M | $861.0K | $836.0K | $868.0K | $253.0K | $987.0K | $778.0K | $620.0K | $262.0K | $419.0K | $915.0K | $1M | $1M | $1M | |
| Cost of Revenue | $25.0K | $32.0K | $51.0K | $49.0K | $46.0K | $44.0K | $58.0K | $68.0K | $44.0K | $34.0K | $47.0K | $41.0K | $54.0K | $44.0K | $53.0K | $56.0K | |
| R&D Expense | $17M | $16M | $17M | $14M | $14M | $13M | $11M | $12M | $11M | $9M | $9M | $9M | $8M | $8M | $8M | $6M | |
| SG&A Expense | $6M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $4M | $3M | $5M | |
| Operating Expenses | $22M | $22M | $24M | $21M | $20M | $20M | $17M | $17M | $18M | $15M | $13M | $15M | $14M | $13M | $11M | $11M | |
| Operating Income | $-22M | $-22M | $7M | $-20M | $-19M | $-19M | $-17M | $-16M | $-17M | $-14M | $-12M | $-15M | $-13M | $-12M | $-10M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $351.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $-11.0K | · | · | · | · | · | · | |
| Net Income | $-24M | $-21M | $6M | $-21M | $-19M | $-19M | $-16M | $-15M | $-16M | $-13M | $-13M | $-13M | $-12M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| EPS (Diluted) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| Shares (Basic) | 63,812,098 | 62,721,869 | · | 52,186,503 | 38,392,716 | 38,235,409 | · | 37,621,495 | 35,800,273 | 35,777,877 | · | 35,243,598 | 34,613,466 | 27,643,549 | · | 20,187,773 | |
| Shares (Diluted) | 63,812,098 | 62,721,869 | · | 52,186,503 | 38,392,716 | 38,235,409 | · | 37,621,495 | 35,800,273 | 35,777,877 | · | 35,243,598 | 34,613,466 | 27,643,549 | · | 20,187,773 | |
| EBITDA | $-22M | $-22M | · | $-20M | $-19M | $-19M | · | $-16M | $-17M | $-14M | · | $-15M | $-13M | $-11M | · | $-813.4K |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $28M | $35M | $42M | $19M | $18M | $22M | $26M | $24M | $23M | $31M | $19M | $16M | $19M | $20M | $735.2K | |
| Short-term Investments | $89M | $66M | $72M | $54M | $15M | $32M | $45M | $41M | $41M | $52M | $57M | $89M | $101M | $108M | $64M | · | |
| Receivables | $51.0K | $84.0K | $95.0K | $52.0K | $83.0K | $89.0K | $92.0K | $115.0K | $80.0K | $67.0K | $99.0K | $86.0K | $171.0K | $76.0K | $96.0K | · | |
| Inventory | $250.0K | $277.0K | $310.0K | $365.0K | $185.0K | $135.0K | $173.0K | $234.0K | $70.0K | $115.0K | $146.0K | $137.0K | $178.0K | $232.0K | $276.0K | · | |
| Prepaid Expense | $977.0K | $1M | $994.0K | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $533.0K | $137.3K | |
| Current Assets | $111M | $96M | $108M | $98M | $36M | $52M | $69M | $69M | $66M | $76M | $89M | $110M | $120M | $130M | $85M | $872.6K | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $993.0K | $921.0K | $849.0K | $778.0K | · | |
| Total Assets | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Accounts Payable | $6M | $6M | $6M | $8M | $5M | $6M | $5M | $5M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $281.6K | |
| Accrued Liabilities | $7M | $7M | $10M | $7M | $7M | $5M | $6M | $7M | $4M | $4M | $5M | $4M | $4M | $3M | $5M | $1M | |
| Current Liabilities | $13M | $14M | $17M | $21M | $17M | $15M | $16M | $16M | $15M | $10M | $11M | $21M | $12M | $12M | $19M | $1M | |
| Capital Leases | $520.0K | $730.0K | $936.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | · | |
| Deferred Tax | · | · | $393.0K | · | · | · | $561.0K | · | · | · | $508.0K | · | · | · | $637.0K | · | |
| Other Non-current Liabilities | $397.0K | $367.0K | $308.0K | $248.0K | $189.0K | $99.0K | $40.0K | · | · | · | · | $266.0K | $213.0K | $249.0K | $196.0K | · | |
| Total Liabilities | $86M | $50M | $51M | $61M | $43M | $42M | $43M | $29M | $28M | $25M | $27M | $37M | $36M | $37M | $43M | $7M | |
| Long-term Debt | · | $15M | $15M | $15M | $15M | $15M | · | · | · | · | · | $10M | $10M | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | $445 | |
| Paid-in Capital | $426M | $424M | $416M | $413M | $348M | $345M | $343M | $340M | $322M | $320M | $317M | $316M | $312M | $310M | $252M | · | |
| Retained Earnings | $-407M | $-383M | $-363M | $-369M | $-348M | $-329M | $-310M | $-294M | $-278M | $-262M | $-249M | $-236M | $-223M | $-211M | $-200M | $-6M | |
| AOCI | $-81.0K | $-40.0K | $60.0K | $45.0K | $16.0K | $37.0K | $52.0K | $98.0K | $-23.0K | $-8.0K | $-10.0K | $-77.0K | $-96.0K | $-35.0K | $-8.0K | · | |
| Stockholders' Equity | $19M | $41M | $54M | $44M | $295.0K | $17M | $33M | $46M | $44M | $57M | $68M | $80M | $89M | $100M | $53M | $-6M | |
| Liabilities + Equity | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Shares Outstanding | 60,105,049 | 58,630,715 | 57,032,963 | 56,464,731 | 38,643,553 | 38,312,512 | 38,194,442 | 37,942,905 | 35,824,571 | 35,784,997 | 35,777,412 | 35,743,972 | 35,743,007 | 31,741,147 | 20,187,850 | 4,450,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96.0K | $90.0K | $82.0K | $81.0K | $81.0K | $83.0K | $84.0K | $76.0K | $74.0K | $74.0K | $72.0K | $71.0K | $73.0K | $71.0K | $70.0K | $54.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $919.0K | $4M | $2M | $1M | $863.0K | $2M | |
| Other Non-cash | · | $-4M | · | · | · | $-909.0K | · | · | · | $-2M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-19M | $-22M | $-2M | $-15M | $-16M | $-17M | $-14M | $-14M | $-10M | $-13M | $-11M | $-10M | $-10M | $-14M | $-9M | $-20M | |
| CapEx | $254.0K | $184.0K | $33.0K | $310.0K | $34.0K | $112.0K | $106.0K | $68.0K | $107.0K | $8.0K | $-3.0K | $19.0K | $27.0K | $35.0K | $54.0K | $224.0K | |
| Investing Cash Flow | $-23M | $10M | $-18M | $-39M | $16M | $13M | $-4M | $557.0K | $10M | $6M | $33M | $13M | $8M | $-44M | $-63M | $-224.0K | |
| Financing Cash Flow | $35M | $6M | $13M | $76M | $-428.0K | $-296.0K | $14M | $15M | $171.0K | $18.0K | $-11M | $4.0K | $86.0K | $57M | $-5M | $-2M | |
| Net Change in Cash | $-8M | $-6M | $-7M | $23M | $401.0K | $-4M | $-3M | $2M | $389.0K | $-7M | $11M | $3M | $-2M | $-1M | $-77M | $88M | |
| Free Cash Flow | · | $-22M | · | · | · | $-17M | · | · | · | $-13M | · | · | · | $-14M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -25404.5% | -20069.1% | · | -2359.2% | -2311.8% | -2179.8% | · | -1655.7% | -2167.0% | -2326.3% | · | -3466.3% | -1416.0% | -991.8% | · | · | |
| Net Margin | -26994.3% | -18810.0% | · | -2419.1% | -2316.2% | -2160.7% | · | -1562.9% | -2054.0% | -2171.5% | · | -3178.0% | -1316.5% | -939.9% | · | · | |
| EBITDA Margin | -25404.5% | -19987.3% | · | -2359.2% | -2311.8% | -2170.3% | · | -1655.7% | -2167.0% | -2314.3% | · | -3466.3% | -1416.0% | -985.7% | · | · | |
| ROA | -30.0% | -25.9% | · | -23.1% | -33.6% | -26.5% | · | -16.1% | -16.1% | -12.3% | · | -14.4% | -8.4% | -7.3% | · | -0.59% | |
| ROE | -242.2% | -71.3% | · | -46.3% | -87.2% | -50.7% | · | -24.5% | -23.9% | -17.2% | · | -36.2% | -28.6% | -22.9% | · | 13.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 7.0 | · | 4.7 | 2.1 | 3.4 | · | 4.2 | 4.6 | 7.3 | · | 5.1 | 10.1 | 10.8 | · | 0.6 | |
| Quick Ratio | 8.2 | 6.9 | · | 4.6 | 2.0 | 3.2 | · | 4.1 | 4.5 | 7.2 | · | 5.1 | 9.9 | 10.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -32.9 | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.1 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.2 | · | 0.6 | 0.6 | 0.4 | · | · | |
| Receivables Turnover | 1.3 | 1.3 | · | 10.3 | 10.3 | 11.1 | · | 9.8 | 6.2 | 8.7 | · | 9.7 | 10.7 | 30.6 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.32 | $0.70 | · | $0.77 | $0.01 | $0.44 | · | $1.22 | $1.23 | $1.60 | · | $2.23 | $2.50 | $3.14 | · | $-1.36 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.02 | $0.02 | $0.02 | · | $0.03 | $0.02 | $0.02 | · | $0.01 | $0.03 | $0.04 | · | · | |
| Cash Flow / Share | · | $-0.35 | · | · | · | $-0.43 | · | · | · | $-0.37 | · | · | · | $-0.52 | · | · | |
| Cash / Share | $0.34 | $0.48 | · | $0.74 | $0.49 | $0.48 | · | $0.67 | $0.66 | $0.65 | · | $0.53 | $0.46 | $0.59 | · | $0.17 | |
| EPS (TTM) | $-0.83 | $-0.95 | · | $-1.81 | $-1.82 | $-1.77 | · | $-1.59 | $-1.56 | $-1.46 | · | $-1.47 | $-1.60 | $-2.02 | · | $-1.91 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $32M | $33M | · | $3M | $3M | $3M | · | $3M | $2M | $2M | · | $4M | $4M | $4M | · | · | |
| Net Income TTM | $-59M | $-55M | · | $-75M | $-70M | $-66M | · | $-58M | $-56M | $-52M | · | $-46M | $-43M | $-39M | · | $-24M | |
| Market Cap | $259M | $249M | · | $140M | $104M | $164M | · | $195M | $292M | $189M | · | $312M | $250M | $621M | · | $44M | |
| P/E | -5.2 | -4.5 | · | -1.4 | -1.5 | -2.4 | · | -3.2 | -5.2 | -3.6 | · | -5.9 | -4.4 | -9.7 | · | -5.2 | |
| P/S | 8.1 | 7.6 | · | 49.7 | 35.2 | 56.8 | · | 73.7 | 140.4 | 85.1 | · | 86.6 | 57.6 | 162.1 | · | · | |
| P/B | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | -7.3 | |
| P / Tangible Book | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | · | |
| P / Cash Flow | · | -11.2 | · | · | · | -9.9 | · | · | · | -14.4 | · | · | · | -43.2 | · | · | |
| Earnings Yield | -19.2% | -22.4% | · | -73.0% | -67.9% | -41.4% | · | -30.9% | -19.1% | -27.7% | · | -16.9% | -22.9% | -10.3% | · | -19.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $33M | $3M | $3M | $4M | · |
| Margen Operativo % | -154.7% | -2437.5% | -1866.2% | · | · |
| Beneficio neto | $-53M | $-61M | $-49M | $-34M | $-378.8K |
| EPS Diluido | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 6.4 | 4.3 | 8.0 | 0.2 | 10.9 |
| Ratio Rápido | 6.4 | 4.1 | 7.8 | 0.1 | 10.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-49M | $-51M | $-46M | · | · |
Propietarios institucionales (13F) 86 declarantes · $124.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
86
Valor en tenencia
$124.3M
Nuevas posiciones
27
Posiciones cerradas
13
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 27 (+8 vs trimestre anterior) | 13 (0 vs trimestre anterior) | 22 (-2 vs trimestre anterior) | 15 (+1 vs trimestre anterior) | +4.0M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $41 234 412 | 9 556 063 | 33,19% | Acciones |
| PERCEPTIVE ADVISORS LLC | $21 738 564 | 5 037 906 | 17,50% | Acciones |
| BlackRock, Inc. | $10 832 320 | 2 510 387 | 8,72% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $8 728 883 | 2 022 916 | 7,03% | Acciones |
| VANGUARD GROUP INC | $6 658 907 | 1 604 556 | 5,36% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $4 350 317 | 1 007 908 | 3,50% | Acciones |
| Alyeska Investment Group, L.P. | $4 315 000 | 1 000 000 | 3,47% | Acciones |
| Propel Bio Management, LLC | $3 869 265 | 896 701 | 3,11% | Acciones |
| STATE STREET CORP | $2 226 756 | 516 050 | 1,79% | Acciones |
| RICE HALL JAMES & ASSOCIATES, LLC | $1 829 560 | 424 000 | 1,47% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 508 282 | 349 544 | 1,21% | Acciones |
| NORTHERN TRUST CORP | $1 482 807 | 343 640 | 1,19% | Acciones |
| UBS Group AG | $1 405 711 | 325 773 | 1,13% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 261 072 | 292 253 | 1,01% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 186 508 | 274 973 | 0,95% | Acciones |
| Knott David M Jr | $1 094 504 | 253 651 | 0,88% | Acciones |
| Flat Footed LLC | $1 084 670 | 251 372 | 0,87% | Acciones |
| Simplify Asset Management Inc. | $946 655 | 219 387 | 0,76% | Acciones |
| GOLDMAN SACHS GROUP INC | $775 000 | 179 606 | 0,62% | Acciones |
| DAFNA Capital Management LLC | $547 319 | 126 841 | 0,44% | Acciones |
| AMH Equity Ltd | $411 680 | 166 000 | 0,33% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $388 350 | 90 000 | 0,31% | Acciones |
| IFP Advisors, Inc | $386 659 | 89 608 | 0,31% | Acciones |
| Daytona Street Capital LLC | $379 336 | 96 398 | 0,31% | Acciones |
| Bank of New York Mellon Corp | $371 534 | 86 103 | 0,30% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347 789 | 80 600 | 0,28% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $283 944 | 65 804 | 0,23% | Acciones |
| CITADEL ADVISORS LLC | $242 464 | 56 191 | 0,20% | Acciones |
| Nuveen, LLC | $224 889 | 52 118 | 0,18% | Acciones |
| Holos Integrated Wealth LLC | $204 316 | 51 595 | 0,16% | Acciones |
| Cubist Systematic Strategies, LLC | $193 172 | 77 892 | 0,16% | Acciones |
| NewEdge Advisors, LLC | $190 218 | 44 083 | 0,15% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $187 642 | 43 486 | 0,15% | Acciones |
| DEUTSCHE BANK AG\ | $171 383 | 39 672 | 0,14% | Acciones |
| XTX Topco Ltd | $167 482 | 38 814 | 0,13% | Acciones |
| WELLS FARGO & COMPANY/MN | $156 876 | 36 356 | 0,13% | Acciones |
| HighTower Advisors, LLC | $152 643 | 35 375 | 0,12% | Acciones |
| LASRY MARC | $150 955 | 60 869 | 0,12% | Acciones |
| Affinity Asset Advisors, LLC | $144 121 | 33 400 | 0,12% | Acciones |
| RHUMBLINE ADVISERS | $137 813 | 31 940 | 0,11% | Acciones |
| MORGAN STANLEY | $125 826 | 29 160 | 0,10% | Acciones |
| ALGERT GLOBAL LLC | $122 917 | 28 486 | 0,10% | Acciones |
| Meramec Financial Planners, LLC | $114 600 | 30 000 | 0,09% | Acciones |
| TWO SIGMA ADVISERS, LP | $112 465 | 27 100 | 0,09% | Acciones |
| AXQ CAPITAL, LP | $109 808 | 25 448 | 0,09% | Acciones |
| Invesco Ltd. | $106 533 | 24 689 | 0,09% | Acciones |
| MetLife Investment Management, LLC | $103 534 | 23 994 | 0,08% | Acciones |
| BANK OF AMERICA CORP /DE/ | $102 792 | 23 822 | 0,08% | Acciones |
| JPMORGAN CHASE & CO | $99 181 | 20 880 | 0,08% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $97 359 | 22 563 | 0,08% | Acciones |
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RTW Investments, LP, RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., Roderick Wong ×8 presentaciones | 29 de abril de 2026 | 19,20% | Enmienda | · | SEC |
| HSAC 2 Holdings, LLC ×3 presentaciones | 7 de agosto de 2024 | · | Presentación inicial | · | SEC |
| Geoffrey W. Smith | 7 de febrero de 2023 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 21 insiders · 11 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| David P Hochman | Chief Executive Officer and Chairperson | 10 de septiembre de 2026 F | 432 916 | 5 | 0 | $149 150 |
| Roderick Wong, M.D. | Chief Executive Officer | 24 de enero de 2023 P | 2 808 512 | 0 | 0 | $0 |
| Andrew Lawrence Taylor | Chief Financial Officer | 26 de agosto de 2026 F | 589 989 | 0 | 0 | $0 |
| Michael Kaswan | Chief Financial Officer | 26 de enero de 2023 A | 162 574 | 0 | 0 | $0 |
| Darren Sherman | President and Chief Operating Officer | 1 de octubre de 2026 S | 1 119 402 | 1 | 5 | $-342 290 |
| Joshua Aiello | Principal Accounting Officer | 26 de agosto de 2026 F | 18 441 | 0 | 0 | $0 |
| William Reed Little | Executive Vice President, Corporate Development & Strategy | 30 de mayo de 2024 P | 307 859 | 0 | 0 | $0 |
| George Papandreou | General Manager and Senior Vice President, Focal Therapies | 8 de mayo de 2024 A | 42 000 | 0 | 0 | $0 |
| Yuval Mika | General Manager and Chief Technology Officer, Bioelectronic Therapies | 8 de mayo de 2024 A | 158 905 | 0 | 0 | $0 |
| Stephanie A Sirota | VP of Corp Stratege and Comm | 4 de agosto de 2020 P | 20 000 | 0 | 0 | $0 |
| Alice Lee | VP Operations, Sec & Treasurer | 4 de agosto de 2020 P | 10 000 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | Consejero | 23 de junio de 2026 A | 66 038 | 0 | 0 | $0 |
| Jason Aryeh | Consejero | 23 de junio de 2026 A | 118 118 | 2 | 0 | $37 481 |
| Eric A Rose MD | Consejero | 20 de junio de 2024 A | 7 544 | 0 | 0 | $0 |
| Geoffrey Wade Smith | Consejero | 20 de julio de 2023 A | 20 913 | 0 | 0 | $0 |
| HSAC 2 Holdings, LLC | Propietario del 10% | 5 de agosto de 2024 J | 1 705 705 | 0 | 0 | $0 |
| Medtronic plc | Propietario del 10% | 30 de enero de 2023 P | 4 999 423 | 0 | 0 | $0 |
| Chris Cleary | · | 12 de agosto de 2026 F | 29 153 | 0 | 0 | $0 |
| John Prosper Mack | · | 12 de agosto de 2026 F | 66 544 | 0 | 0 | $0 |
| David Pacitti | · | 12 de agosto de 2026 F | 54 750 | 0 | 0 | $0 |
| Eric S Fain | · | 12 de agosto de 2026 F | 99 630 | 1 | 0 | $82 600 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 10 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,05% | 135 778 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 4 255 SH | 2 de octubre de 2026 | Diario |
| IWO · iShares Trust | 0,02% | 374 286 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 228 058 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 42 916 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 815 602 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 19 057 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 498 632 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 470 063 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 999 SH | 19 de agosto de 2026 | Diario |
OBIO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 13 analistas
COMPRA
Objetivo mediano
$11.00
+84,9%
3 23,1%
Compra fuerte
8 61,5%
Compra
2 15,4%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
7 analistas · 2026-10-03Objetivo medio $12.43 +108,9%
← Por Debajo de Todos los Objetivos
Precio Actual $5.95
Mín$9.00
Media$12.43
Máx$20.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | · |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| MOBI | · | · | · | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026